Calithera Biosciences, Inc. (CALA)

Calithera Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2022	2021	2020	2019	2018
Cash & Equivalents	25.45	59.54	107.15	60.44	51.06
Short-Term Investments	0	0	8.01	96.92	85.1
Cash & Cash Equivalents	25.45	59.54	115.15	157.36	136.15
Cash Growth	-57.25%	-48.30%	-26.82%	15.58%	-26.86%
Receivables	0	0	1.54	0.48	2
Inventory	0	0	-1.54	-0.48	-2
Other Current Assets	1.17	1.92	3.55	2.44	4.1
Total Current Assets	26.62	61.45	118.7	159.8	140.25
Property, Plant & Equipment	1.78	3.03	6.44	8.25	1.46
Other Long-Term Assets	0.27	0.27	0.44	0.72	1.01
Total Long-Term Assets	2.05	3.3	6.88	8.97	2.47
Total Assets	28.68	64.76	125.59	168.77	142.73
Accounts Payable	0.73	3.65	1.99	2.05	1.25
Deferred Revenue	0	8.37	13.05	1.55	2.47
Current Debt	1.53	1.37	1.9	1.48	0
Other Current Liabilities	5.13	0.61	1.45	14.55	11.17
Total Current Liabilities	7.39	14.01	18.4	19.62	14.88
Long-Term Debt	0.14	1.67	4.82	6.72	0
Other Long-Term Liabilities	0.76	40.7	0	0	1.13
Total Long-Term Liabilities	0.89	42.37	4.82	6.72	1.13
Total Liabilities	8.28	56.37	23.22	26.34	16.01
Total Debt	1.67	3.04	6.72	8.2	0
Debt Growth	-45.20%	-54.75%	-18.03%	-	-
Common Stock	0	0.01	0.01	0.01	0
Retained Earnings	-512.62	-491.33	-376.24	-286.1	-196.17
Comprehensive Income	0	-40.7	0	0.04	-0.11
Shareholders' Equity	20.39	-491.33	-376.24	-286.1	-196.17
Total Liabilities and Equity	28.68	-434.95	-353.02	-259.76	-180.16
Net Cash / Debt	23.79	56.5	108.43	149.17	136.15
Net Cash / Debt Growth	-57.90%	-47.90%	-27.31%	9.56%	-16.87%
Net Cash Per Share	4.76	15.30	31.51	63.06	74.39
Working Capital	19.23	47.45	100.3	140.17	125.37
Book Value Per Share	4.08	-133.04	-109.34	-120.94	-107.19

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.